Showing results (291-300 of 610) with videos related to
Sort By:
Pageof 61
British Journal of Haematology|May 1, 1978
Inhibition of plasmin by antithrombin-heparin complex. II. During thrombolytic therapy in manD Collen, N Semeraro, P Telesforo, et al.Thrombosis and Haemostasis|August 1, 1994
On the immunogenicity of recombinant staphylokinase in patients and in animal modelsS M Vanderschueren, J M Stassen, D CollenThe Journal of Laboratory and Clinical Medicine|February 1, 1983
Complexes between tissue-type plasminogen activator and proteinase inhibitors in human plasma, identified with an immunoradiometric assayD C Rijken, I Juhan-Vague, D CollenJournal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
High resolution mapping of the B cell epitopes of staphylokinase in humans using negative selection of a phage-displayed antigen libraryS Jenné, K Brepoels, D Collen, et al.Thrombosis and Haemostasis|October 28, 1987
Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis modelD Collen, J M Stassen, F De CockArteriosclerosis (Dallas, Tex.)|January 1, 1988
Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitusJ Auwerx, R Bouillon, D Collen, et al.Journal of Molecular Biology|June 27, 1997
Epitope mapping by negative selection of randomized antigen libraries displayed on filamentous phageL Jespers, S Jenné, I Lasters, et al.Thrombosis and Haemostasis|October 1, 1996
A pilot study on bolus administration of recombinant staphylokinase for coronary artery thrombolysisS Vanderschueren, D Collen, F van de WerfCurrent Atherosclerosis Reports|December 21, 2000
The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studiesA Luttun, M Dewerchin, D Collen, et al.Pageof 61